AJU IB Investment Company’s Sutro Biopharma STRO Stock Holding History

AJU IB Investment Company’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,500	Closed	-$436K	–	5
2026 Q1	$436K	Hold	17,500	–	–	1.43%	5
2025 Q4	$202K	Hold	17,500	–	–	0.89%	7
2025 Q3	$153K	Hold	17,500	–	–	0.13%	7
2025 Q2	$125K	Hold	17,500	–	–	0.14%	7
2025 Q1	$114K	Hold	17,500	–	–	0.14%	8
2024 Q4	$322K	Buy	+17,500	New	+$534K	0.31%	6
2022 Q3	$971K	Hold	17,500	–	–	1.66%	7
2022 Q2	$912K	Hold	17,500	–	–	1.77%	7
2022 Q1	$1.44M	Hold	17,500	–	–	2.22%	7
2021 Q4	$2.6M	Hold	17,500	–	–	3.63%	6
2021 Q3	$3.31M	Hold	17,500	–	–	2.13%	5
2021 Q2	$3.25M	Hold	17,500	–	–	1.88%	5
2021 Q1	$3.98M	Hold	17,500	–	–	1.5%	5
2020 Q4	$3.8M	Buy	+17,500	New	+$2.9M	1.44%	5

Other funds holding STRO

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

OCWP

Owl Creek Wealth Partners Denver, Colorado $342M AUM

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

PWA

Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

BWL

Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return

AJU IB Investment Company's STRO Position: Q2 2026 in Review

AJU IB Investment Company sold out of Sutro Biopharma (STRO) in Q2 2026, closing a stake of 17,500 shares — an estimated $436K sold.

AJU IB Investment Company first reported a position in STRO in Q4 2020 and held it in 14 quarters. The position peaked at $3.98M in Q1 2021. 8 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

AJU IB Investment Company reported no remaining Sutro Biopharma position as of Q2 2026 after selling out during the quarter.
AJU IB Investment Company sold 17,500 Sutro Biopharma shares in Q2 2026, an estimated $436K.
AJU IB Investment Company first reported a position in Sutro Biopharma in Q4 2020 and held it in 14 quarters.
AJU IB Investment Company's Sutro Biopharma position peaked at $3.98M in Q1 2021.
8 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on AJU IB Investment Company's 13F filing for Q2 2026.